TWD 40.9
(0.25%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 654.03 Million TWD | -3.31% |
2022 | 676.42 Million TWD | 3.22% |
2021 | 655.34 Million TWD | 4.87% |
2020 | 624.93 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 656.43 Million TWD | 0.37% |
2024 Q2 | 652.38 Million TWD | -0.62% |
2023 Q2 | 667.75 Million TWD | 1.13% |
2023 FY | 654.03 Million TWD | -3.31% |
2023 Q1 | 660.26 Million TWD | 0.0% |
2023 Q4 | 654.03 Million TWD | -2.32% |
2023 Q3 | 669.53 Million TWD | 0.27% |
2022 Q4 | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | 68.539% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | 44.355% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | 46.116% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 93.377% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 94.424% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 93.951% |
Center Laboratories, Inc. | 27 Billion TWD | 97.578% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 74.478% |
InnoPharmax Inc. | 524.19 Million TWD | -24.769% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | 67.182% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | 58.535% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | 63.918% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | 64.864% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 78.466% |
UniPharma Co., Ltd. | 350.07 Million TWD | -86.828% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | 70.52% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | 32.796% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | 18.427% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -49.297% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -20.527% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | 53.279% |